AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs

AstraZeneca employs more than 1,000 people in Australia and New Zealand, and again its ranks will grow. The company pledged a $133 million investment in manufacturing, enabling it to grow exports and deliver more medicines to patients with asthma and chronic obstructive pulmonary disease.